Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users

European Journal of Epidemiology

Volumn 15, Issue 8, 1999, Pages 699-704

  Pallás, José R ^a   Fariñas Álvarez, Concepción ^b   Prieto, Dolores ^b   Delgado Rodríguez, Miguel ^b,c  

^a Centro Penitenciario de Santander   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; Injecting drug users; Prisoners; Seroepidemiology

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRISONER; SEROEPIDEMIOLOGY; SPAIN;

ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; ODDS RATIO; PRISONERS; RISK FACTORS; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0344200080     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007619614350     Document Type: Article

References (19)

1. Rhodes T, Hunter GM, Stimson GV, Donoghoe MC, Noble A, Parry J, Chalmers C. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: Injecting careers, positivity and risk behaviour. Addiction 1996; 91: 1457-1467.
2. Stark K, Muller R, Bienzle U, Guggenmoos-Holzmann I. Frontloading: A risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. AIDS 1996; 10: 311-317.
3. Zeldis JB, Jain S, Kuramoto IK, Richards C, Sazama K, Samuels S, Holland PV, Flynn N. Seroepidemiology of viral infections among intravenous drug users in northern California. Western J Med 1992; 156: 30-35.
4. Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW. Hepatitis B and C in New South Wales prisons: Prevalence and risk factors. Med J Australia 1997; 166: 127-130.
5. Rotily M, Galinier-Pujol A, Obadia Y, Moatti JP, Toubiana P, Vernay-Vaisse C, Gastaut JA. HIV testing, HIV infection and associated risk factors among inmates in south-eastern French prisons. AIDS 1994; 8: 1341-1344.
6. Caylá JA, Marco A, Bedoya A, Vidal R, López-Colomés JL, Gatell JM. Differential characteristics of AIDS patients with a history of imprisonment. Int J Epidemiol 1995; 24: 1188-1196.
7. Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AJ, Gallo RC, Blattner WA. Screening test for HTLV-III (AIDS agent) antibodies-specificity, sensitivity and applications. JAMA 1985; 203: 221-225.
8. Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 1996; 49: 907-916.
9. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129: 125-137.
10. Thompson WD. Statistical analysis of case-control studies. Epidemiol Rev 1994; 16: 33-50.
11. Dixon WJ. BMDP statistical software manual. Berkeley: University of California Press, 1992.
12. Behrendt C, Kending N, Dambita C, Horman J, Lawlor J, Vlahov D. Voluntary testing for HIV in a prison population with a high prevalence of HIV. Am J Epidemiol 1994; 139: 918-926.
13. Dye S, Isaacs C. Intravenous drug misuse among prison inmates: Implications for spread of HIV. Br Med J 1991; 302: 1506.
14. Vlahov D, Brewer TF, Castro KG, Narkunas JP, Salive ME, Ullrich J, Muñoz A. Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA 1991; 265: 1129-1132.
15. Dufour A, Alary M, Poulin C, Allar F, Noel L, Trottier G, Lépine D, Hankins C. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS 1996; 10: 1009-1015.
16. Smyth R, Keenan E, Dorman A, O'Connor J. Hepatitis C infection among injecting drug users attending the National Drug Treatment Centre. Irish J Med Sci 1995; 164: 267-268.
17. Grupo Noroeste para el estudio de la Hepatitis por virus C en el medio penitenciario. Seroprevalencia de infección por virus C de la hepatitis en población reclusa del Noroeste de España a su ingreso en prisión, [Seroprevalence of infection by hepatitis C virus on entry to prison in the prison population in the northeast of Spain]. Revista Española de Salud Pública 1998; 72: 43-51.
18. Muller R, Stark K, Guggenmoos-Holzmann I, Wirth D, Bienzle U. Imprisonment: A risk factor for HIV infection counteracting education and prevention programmes for intravenous drug users. AIDS 1995; 9: 183-190.
19. Shewan D, Gemmell M, Davies JB. Behavioral change amongst drug injectors in Scottish prisons. Soc Sci Med 1994; 39: 1585-1586.